Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 9061 | $27.69 - $28.82 | $251,273 |
| 2024-11-15 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 9061 | $21.10 - $21.10 | $191,187 |
| 2024-11-06 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 10000 | $35.19 - $35.19 | $351,890 |
| 2024-11-06 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 10000 | $0.61 - $0.61 | $6,150 |
| 2024-11-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 50716 | $31.25 - $32.94 | $1,601,250 |
| 2024-11-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
M | Common Stock | A | 40716 | $21.09 - $21.09 | $858,700 |
| 2024-11-01 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
S | Common Stock | D | 108366 | $31.47 - $32.50 | $3,438,311 |
| 2024-11-01 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
M | Common Stock | A | 108366 | $21.10 - $21.10 | $2,286,522 |
| 2024-10-30 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 20000 | $32.53 - $32.62 | $651,959 |
| 2024-10-30 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 20000 | $21.10 - $21.10 | $421,999 |
| 2024-10-16 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
S | Common Stock | D | 91634 | $31.12 - $32.12 | $2,878,036 |
| 2024-10-16 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
M | Common Stock | A | 91634 | $21.10 - $21.10 | $1,933,476 |
| 2024-10-14 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 40000 | $30.15 - $30.15 | $1,206,080 |
| 2024-10-14 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
M | Common Stock | A | 40000 | $21.09 - $21.09 | $843,600 |
| 2024-10-15 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 20961 | $30.03 - $30.93 | $636,489 |
| 2024-10-15 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 19825 | $0.61 - $0.61 | $12,192 |
| 2024-10-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 10000 | $28.18 - $28.18 | $281,770 |
| 2024-09-20 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 5500 | $27.65 - $27.65 | $152,086 |
| 2024-09-20 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 5500 | $0.61 - $0.61 | $3,382 |
| 2024-09-16 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 8393 | $27.52 - $27.56 | $231,173 |
| 2024-09-16 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 8393 | $0.61 - $0.61 | $5,160 |
| 2024-09-10 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 568 | $26.18 - $26.18 | $14,870 |
| 2024-09-10 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 637 | $26.18 - $26.18 | $16,676 |
| 2024-08-23 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 14051 | $27.51 - $27.53 | $386,713 |
| 2024-08-23 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
M | Common Stock | A | 14051 | $0.61 - $0.61 | $8,641 |
| 2024-08-16 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
M | Common Stock | A | 24538 | $0.61 - $0.61 | $15,090 |
| 2024-08-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 5000 | $26.44 - $27.23 | $133,754 |
| 2024-07-23 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
S | Common Stock | D | 161855 | $26.71 - $28.01 | $4,381,865 |
| 2024-07-23 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
M | Common Stock | A | 161855 | $7.01 - $7.01 | $1,134,440 |
| 2024-07-16 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
S | Common Stock | D | 34811 | $28.05 - $28.05 | $976,274 |
| 2024-07-16 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
M | Common Stock | A | 29803 | $7.01 - $7.01 | $208,889 |
| 2024-06-28 | Akero Therapeutics, Inc. | Rolph Timothy
(Chief Scientific Officer) |
A | Common Stock | A | 1064 | $19.94 - $19.94 | $21,217 |
| 2024-06-28 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
A | Common Stock | A | 1064 | $19.94 - $19.94 | $21,217 |
| 2024-06-28 | Akero Therapeutics, Inc. | Lamy Patrick
(Senior VP, Commercial Strategy) |
A | Common Stock | A | 221 | $19.94 - $19.94 | $4,406 |
| 2024-06-28 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
A | Common Stock | A | 1064 | $19.94 - $19.94 | $21,217 |
| 2024-07-01 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 5000 | $23.40 - $23.40 | $117,020 |
| 2024-06-28 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
A | Common Stock | A | 1064 | $19.94 - $19.94 | $21,217 |
| 2024-06-11 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 2516 | $22.64 - $22.64 | $56,964 |
| 2024-06-11 | Akero Therapeutics, Inc. | Yale Catriona
(Chief Development Officer) |
S | Common Stock | D | 2825 | $22.64 - $22.64 | $63,960 |
| 2024-06-11 | Akero Therapeutics, Inc. | White William Ric...
(Chief Financial Officer) |
S | Common Stock | D | 2831 | $22.64 - $22.64 | $64,093 |
| 2024-06-11 | Akero Therapeutics, Inc. | Rolph Timothy
(Chief Scientific Officer) |
S | Common Stock | D | 2380 | $22.64 - $22.64 | $53,885 |
| 2024-06-11 | Akero Therapeutics, Inc. | Lamy Patrick
(Senior VP, Commercial Strategy) |
S | Common Stock | D | 569 | $22.64 - $22.64 | $12,882 |
| 2024-06-11 | Akero Therapeutics, Inc. | Cheng Andrew
(President and CEO) |
S | Common Stock | D | 7894 | $22.64 - $22.64 | $178,728 |
| 2024-06-03 | Akero Therapeutics, Inc. | Young Jonathan
(Chief Operating Officer) |
S | Common Stock | D | 5000 | $19.29 - $19.29 | $96,440 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |